EpiCept News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

09.05.18	East Coast vs. West Coast: Where Americans Are Traveling in 2018 (PR Newswire)
03.05.18	Wheaties™ Launches Box Featuring Basketball Superstar Kyrie Irving and His Title Character from Lionsgate's Upcoming Film "Uncle Drew" (PR Newswire)
24.04.18	Henry Schein to Webcast First Quarter 2018 Conference Call on Tuesday, May 8, 2018 at 10:00 A.M. ET (PR Newswire)
26.02.18	Allergan to Present at The Cowen and Company 38th Annual Health Care Conference (PR Newswire)
25.08.17	CBRN Defense Market by Type, Equipment & End User - Global Forecast to 2022 (PR Newswire)
17.05.17	UPM Pharmaceuticals Celebrates Commitment to Quality on 100-Year Anniversary of its Bristol Manufacturing Site (PR Newswire)
25.04.17	Gainers & Losers Of Apr.24: PZRX, BCR, IMNP, ACHN, AKTX... (RTTNews)
24.04.17	Robert J. Mylod, Jr. Named to The Priceline Group's Board of Directors (PR Newswire)
24.04.17	Immune Pharmaceuticals Announces Corporate Restructuring (PR Newswire)
24.04.17	Immune Receives Nasdaq Letter (PR Newswire)
24.04.17	Drug Makers Stocks Under Scanner -- Bristol-Myers, AstraZeneca, Eli Lilly, and Immune Pharma (PR Newswire)
21.04.17	Gainers & Losers Of Apr.20: IMNP, AKTX, IMGN, ALDX, KMPH... (RTTNews)
20.04.17	Immune Pharmaceuticals Signs Letter of Intent with Pint Pharma Regarding License and Commercializion of Ceplene® in Latin America (PR Newswire)
13.04.17	AERI's Rocket Hits Target, ENTL Gets FDA Nod, NOVN Jumps On Positive Trial Data (RTTNews)
12.04.17	Immune Pharmaceuticals Announces 1-for-20 Reverse Stock Split (PR Newswire)
17.03.17	Technical Reports on Drug Makers Stocks -- Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and Immune Pharma (PR Newswire)
13.03.17	Immune Pharmaceuticals Granted Additional Time to Comply with Nasdaq Listing Requirement (PR Newswire)
17.02.17	Immune Pharmaceuticals Announces the launch of REMAIN ™ , an international Overall Survival study with Ceplene® and low dose Proleukin® in REmission MAINtenance in Acute Myeloid Leukemia (PR Newswire)
07.02.17	Technical Reports on Drug Makers Stocks -- Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and Immune Pharma (PR Newswire)
06.02.17	Purcell Julie & Lefkowitz LLP Is Investigating Immune Pharmaceuticals Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (PR Newswire)
27.01.17	Immune Pharmaceuticals Appoints New Chairman of the Board of Directors (PR Newswire)
23.01.17	Immune Pharmaceuticals Enters a Research Partnership to Develop Mono- and Bispecific Antibodies Against Novel Targets in the Tumor Microenvironment (PR Newswire)
10.01.17	Immune Pharmaceuticals Will Request an Appeal to Regain Compliance with Nasdaq's Minimum Bid Price Rule (PR Newswire)
03.01.17	Drug Makers Stocks on Investors' Radar -- Immune Pharma, Sanofi, Biostar Pharma, and Heron Therapeutics (PR Newswire)
28.11.16	Drug Makers Stocks on Investors' Radar -- Immune Pharma, Sanofi, Biostar Pharma, and Shire (PR Newswire)
22.11.16	Immune Pharmaceuticals Announces Immuno-Oncology R&D Update on December 8, 2016 (PR Newswire)
26.06.15	AQXP Fails To Lead, Concordia To Get Better Visibility, EXAC Gets FDA Nod (RTTNews)
17.03.15	BDSI On Watch, Busy Months Ahead For LJPC, AQXP Awaits Leadership (RTTNews)
15.12.14	Immune Pharma: Board Elects Daniel Kazado As Chairman - Quick Facts (RTTNews)
20.11.14	Immune Pharma Prices Offering At $2.50 Per Unit (RTTNews)
16.10.13	New Data Supports Clinical Rationale for Bertilimumab in Ulcerative Colitis (PR Newswire)
16.10.13	New Data Supports Clinical Rationale for Bertilimumab in Ulcerative Colitis (PR Newswire)
15.10.13	Immune Pharmaceuticals Announces Changes to its Board of Directors (PR Newswire)
15.10.13	Immune Pharmaceuticals Announces Changes to its Board of Directors (PR Newswire)
03.10.13	IMMUNE Pharmaceuticals Inc. to Present at 12th Annual BIO Investor Forum (PR Newswire)
30.09.13	Immune Pharmaceuticals Announces Focus on Capital Raising and Primary Listing in The United States (PR Newswire)
30.09.13	Immune Pharmaceuticals Announces Focus on Capital Raising and Primary Listing in The United States (PR Newswire)
23.09.13	Immune Pharmaceuticals Inc. Trading Symbol is Now IMNP on Both NASDAQ OMX Stockholm Exchange and OTCQX Trading Platform (PR Newswire)
30.08.13	Immune Reports Total Shares Outstanding (PR Newswire)
27.08.13	Immune Pharmaceuticals Restructures Secured Loan Following Completion of Merger (PR Newswire)
26.08.13	Immune Pharmaceuticals Completes Merger with EpiCept Corporation (PR Newswire)
26.08.13	Immune Pharmaceuticals Completes Merger with EpiCept Corporation (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Sonova Hldg	262.10	3.39 %	K V
Lonza Grp	584.80	2.38 %	K V
Logitech Intl	66.76	1.71 %	K V
Part Grp Hldg	1’114.00	1.41 %	K V
Swisscom	544.00	0.74 %	K V
ABB	45.07	0.04 %	K V
Novartis	90.91	-0.22 %	K V
Zurich Insur Gr	581.00	-0.34 %	K V
Roche Hldg G	257.60	-0.88 %	K V
Kuehne+Nagel Int	177.85	-3.24 %	K V

EpiCept Aktie VALOR 22117678 / ISIN US45254C1018

Nachrichten zu EpiCept Corp

Aktien Top/Flop

Meistgelesene Nachrichten